Cecilia Csölle

Cecilia Csölle

Auto-generated profile, based on publicly available information

Cecilia Csölle

Laboratory of Molecular Pharmacology, Institute of Experimental Medicine, Hungarian Academy of Sciences, H-1083 Budapest, Szigony u. 43, Hungary

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2011 in Molecular Neurodegeneration
Verified
Journal Article
Open access
PDF file
ZHZsuzsanna Hracskó
Zsuzsanna Hracskó
MBMária Baranyi
Mária Baranyi
CCCecilia Csölle
Cecilia Csölle
FGFlóra Gölöncsér
Flóra Gölöncsér
EMEmilia Madarasz
Emilia Madarasz
BSBeáta Sperlágh
Beáta Sperlágh
Background: Previous studies indicate a role of P2X7 receptors in processes that lead to neuronal death. The main objective of our study was to examine whether genetic deletion or pharmacological blockade of P2X7 receptors influenced dopaminergic cell death in various models of Parkinson's disease (PD). Results: mRNA encoding P2X7 and P2X4 receptors was up-regulated after treatment of PC12 cells with 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP). P2X7 antagonists protected against MPTP and rotenone induced toxicity in the LDH assay, but failed to protect after rotenone treatment in the MTT assay in PC12 cells and in primary midbrain culture. In vivo MPTP and in vitro rotenone pretreatments increased the mRNA expression of P2X7 receptors in the striatum and substantia nigra of wild-type mice. Basal mRNA expression of P2X4 receptors was higher in P2X7 knockout mice and was further up-regulated by MPTP treatment. Genetic deletion or pharmacological inhibition of P2X7 receptors did not change survival rate or depletion of striatal endogenous dopamine (DA) content after in vivo MPTP or in vitro rotenone treatment. However, depletion of norepinephrine was significant after MPTP treatment only in P2X7 knockout mice. The basal ATP content was higher in the substantia nigra of wild-type mice, but the ADP level was lower. Rotenone treatment elicited a similar reduction in ATP content in the substantia nigra of both genotypes, whereas reduction of ATP was more pronounced after rotenone treatment in striatal slices of P2X7 deficient mice. Although the endogenous amino acid content remained unchanged, the level of the endocannabinoid, 2-AG, was elevated by rotenone in the striatum of wild-type mice, an effect that was absent in mice deficient in P2X7 receptors. Conclusions: We conclude that P2X7 receptor deficiency or inhibition does not support the survival of dopaminergic neurons in an in vivo or in vitro models of PD.

12 November 2009 in BMC Pharmacology
Verified
Journal Article
Open access
PDF file
CCCecília Csölle
Cecília Csölle
RARómeó D Andó
Rómeó D Andó
MBMária Baranyi
Mária Baranyi
JHJózsef Haller
József Haller
BSBeáta Sperlágh
Beáta Sperlágh

1 January 2010 in Frontiers in Neuroscience
Verified
Journal Article
Open access
CCCsölle Cecília
Csölle Cecília
The P2X7 receptor is a ligand-gated ion channel expressed in neuronal, glial and immune cells and implicated in a wide range of pathological conditions, including ischemia and inflammation. P2X7 receptor activation elicits increased release of transmitters in the brain and regulates the maturation and release of proinflammatory cytokine, interleukin-1β (IL-1β). IL-1β is suggested to be involved in the pathophysiology of depression, elicited by peripherally administered bacterial lipopolysaccharide (LPS). To identify genes involved in changes in the P2X7 receptor KO and wild type (WT) mouse amygdala we performed whole mouse genome microarray analysis of mRNA extracted after 6 hours of intaperitoneal LPS/saline injection. For validation of differentially expressed genes, we performed TaqMan real-time RT-PCR. Our microarray studies have identified 8165 transcripts that were significantly affected by the deficiency of P2X7 receptor. Validation experiments revealed that among these genes at least 30 genes could be associated to synaptic signaling, neuroplasticity and thereby to the pathogenesis of depression (e.g. subunits of GABAA, GABAC receptors, AMPA, NMDA2B mGLUR5, mGLUR7 glutamate and adrenergic receptors which were downregulated in KO mice). 287 transcripts were found be more than two-fold over-expressed in the LPS treated groups which can be classified according to their inflammatory biological function: Il4ra, Saa1, chemokine ligands. Our Gene Set Enrichment Analysis (GSEA) showed that 526 sets of genes were significantly enriched in WT genotype mice including acetylcholine and GABA pathways. This study showed that genotype had the most significant effect, indicating that the deletion of P2X7 receptor causes genome-wide alterations of gene expression including depression related genes in mouse amygdala. These results point to the key role of the endogenous activation of P2X7R in the regulation of individual proteins which could be of potential interest for the study of the neurobiological basis underlying psychiatric diseases like depression.